Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes DOI Creative Commons
Hanae F Namba, Coen K.M. Boerhout, Peter Damman

et al.

International Journal of Cardiology, Journal Year: 2025, Volume and Issue: unknown, P. 133176 - 133176

Published: March 1, 2025

Angina with non-obstructive coronary arteries (ANOCA) is increasingly recognized as a significant aspect of chronic syndromes. These patients frequently experience recurrent angina, resulting in high healthcare costs and impaired quality life. Invasive function testing (ICFT) able to identify ANOCA endotypes, which can guide treatment improve Despite Class II recommendations for invasive microvascular assessments the previous 2019 European Society Cardiology (ESC) Guidelines, ICFT has yet translate into widespread clinical practice. Patients poor life reduced functional capacity, highlighting need earlier implementation. The 2024 ESC Guidelines now strongly recommend (Class I, level evidence B) persistent angina despite optimal medical therapy, confirming or excluding uncertain diagnoses on non-invasive B). Consequently, standardized approach optimize management warranted. Therefore, this review aims provide interventional cardiologists contemporary literature practical guideline implementation ICFT. It will discuss following subjects: definitions different an example protocol, discontinuation medication prior ICFT, use radial cocktail, target vessel testing, acetylcholine injection techniques rechallenge, adenosine techniques, order interpretation safety feasibility, pharmacological treatment.

Language: Английский

Focus on coronary atherosclerosis in athletes, angina with non-obstructive coronary arteries, mechanisms of acute vascular syndromes, and Marfan syndrome DOI Creative Commons
Filippo Crea

European Heart Journal, Journal Year: 2025, Volume and Issue: 46(10), P. 877 - 881

Published: March 7, 2025

Language: Английский

Citations

0
Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes DOI Creative Commons
Hanae F Namba, Coen K.M. Boerhout, Peter Damman

et al.

International Journal of Cardiology, Journal Year: 2025, Volume and Issue: unknown, P. 133176 - 133176

Published: March 1, 2025

Angina with non-obstructive coronary arteries (ANOCA) is increasingly recognized as a significant aspect of chronic syndromes. These patients frequently experience recurrent angina, resulting in high healthcare costs and impaired quality life. Invasive function testing (ICFT) able to identify ANOCA endotypes, which can guide treatment improve Despite Class II recommendations for invasive microvascular assessments the previous 2019 European Society Cardiology (ESC) Guidelines, ICFT has yet translate into widespread clinical practice. Patients poor life reduced functional capacity, highlighting need earlier implementation. The 2024 ESC Guidelines now strongly recommend (Class I, level evidence B) persistent angina despite optimal medical therapy, confirming or excluding uncertain diagnoses on non-invasive B). Consequently, standardized approach optimize management warranted. Therefore, this review aims provide interventional cardiologists contemporary literature practical guideline implementation ICFT. It will discuss following subjects: definitions different an example protocol, discontinuation medication prior ICFT, use radial cocktail, target vessel testing, acetylcholine injection techniques rechallenge, adenosine techniques, order interpretation safety feasibility, pharmacological treatment.

Language: Английский

Citations

0